Sanofi-Aventis to invest in R&D in Spain
Business Investments
01 Apr 2012
France-based pharmaceutical company Sanofi-aventis plans to invest $1.3 million in research and development (R&D) projects of Barcelona's international biomedical research institute CRG.
The projects include cell reprogramming, the application of synthetic biology technology to treat lung diseases, the influence of genes as factor for some diseases and tuberculosis treatment, the director of CRG, Luis Serrano, said.
Source: IPA WORLD, 8/3/2012
Related News and Success stories.
-
26 Oct 2025
See more Chinese investment in Catalonia triples compared to the previous five-year periodChinese investment in Catalonia triples compared to the previous five-year period
-
23 Oct 2025
See more US company Elian to invest over €200 million to expand its plant-based protein facility in BarcelonaUS company Elian to invest over €200 million to expand its plant-based protein facility in Barcelona
-
20 Oct 2025
See more Danish company NORMAL invests €20M in Catalonia for first Spanish logistics hub, creating 300 jobsDanish company NORMAL invests €20M in Catalonia for first Spanish logistics hub, creating 300 jobs
-
20 Oct 2025
See more Barcelona becomes the first Fraunhofer headquarters in Spain, reinforcing Catalonia’s scientific leadershipBarcelona becomes the first Fraunhofer headquarters in Spain, reinforcing Catalonia’s scientific leadership
